filmov
tv
Adaptimmune Presentation at 39th Annual J.P. Morgan Healthcare Conference
Показать описание
Adaptimmune's CEO Adrian Rawcliffe and CMO Elliot Norry, MD, presents at the Virtual 39th Annual J.P. Morgan Healthcare Conference on January 14th, 2021.
0:40:18
Adaptimmune Presentation at 39th Annual J.P. Morgan Healthcare Conference
0:03:39
Adaptimmune's allogeneic or 'off-the-shelf' cell therapies.
0:08:42
SITC 2020 - Adaptimmune's SURPASS Poster
0:05:26
Adaptimmune ASGCT 2021
0:33:19
39th Annual JP Morgan Healthcare Conference Presentation
0:14:57
Adaptimmune
0:14:56
Adaptimmune - Company Presentation
0:03:53
Dennis Williams, SVP Late Stage Development, reflects on Sarcoma Awareness Month.
0:03:48
Manufacturing at Adaptimmune
0:13:09
Adaptimmune
0:12:06
Adaptimmune
0:09:35
AACR Annual Virtual Meeting 2021 - Focus on our SURPASS and ADP-A2AFP trials
0:03:22
Our Research: A Rich Cell Therapy Pipeline for the Future
0:07:44
E. Norry & D. Williams present initial data from SPEARHEAD-1 trial
0:14:35
Adaptimmune
0:15:36
Adaptimmune
0:15:36
Biomea Fusion Presents at the 39th Annual J.P. Morgan Healthcare Conference
0:00:47
Jump Start Kinase Drug Discovery using A-SKIP
0:04:54
Adaptimmune Therapeutics shares update on its late-stage clinical pipeline assets to treat cancer
0:07:45
LSX World Congress 2019 Presentations - BrainPatch
0:01:09
SPEARHEAD-1: ADP-A2M4 in synovial sarcoma and MRCLS
0:00:47
Stephane Bancel on the importance of transparency
0:13:31
LSX World Congress 2019 Presentations - Medopad
0:06:02
Adaptimmune: SPEAR T-cells
Комментарии